Jones Financial Companies, L.L »

Alnylam Pharmaceuticals shares owned by Jones Financial Companies, L.L

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Jones Financial Companies, L.L from 13F filings

Historical chart of Jones Financial Companies, L.L investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Jones Financial Companies, L.L consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Jones Financial Companies, L.L

Quarter filed Position value Share count Share price at filing
2026-03-31 $23M 74k 317.36
2025-12-31 $310k 780 397.65
2025-09-30 $242k 542 446.40
2025-06-30 $187k 572 326.00
2025-03-31 $113k 419 268.46
2024-12-31 $63k 266 235.31
2022-12-31 $1.0k 4 250.00

More positions owned by Jones Financial Companies, L.L

Vanguard Index Tr Etf (VUG)
Ishares Core Us Aggregate Bond Etf (AGG)
Ishares Core S&p 500 Etf Etf (IVV)
Vanguard S&p 500 Etf Etf (VOO)
Vanguard Index Tr Etf (VTV)
Ishares Trust Core Msci Eafe Etf (IEFA)
Ishares Russell Midcap Etf (IWR)
Spdr Ser Tr Etf (SPYM)
Vanguard Mid Cap Etf Etf (VO)
Vanguard Index Trust Etf (VV)
Ishares Etf (SCZ)
Ishares Core Universal Usd Bd Etf (IUSB)
Ishares Russell 1000 Etf (IWB)
Ishares Broad Usd High Yield Etf (USHY)
Vanguard Ftse Developed Etf (VEA)

View all positions for Jones Financial Companies, L.L

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
BlackRock
Capital Research Global Investors
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Geode Capital Management
Baillie Gifford & Co
Two Sigma Investments
Wellington Management Company
Dodge & Cox
American Century Companies
D. E. Shaw & Co
ClearBridge Advisors

View all funds holding Alnylam Pharmaceuticals